Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Nausea × Olanzapine × Clear all

Phase

Phase 3 5 Phase 2 5 Phase 2/3 2

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 2 Nausea 2 Postoperative Nausea and Vomiting 1 Neoplasms 1 Muscular Atrophy 1 Child Nutrition Disorders 1

Interventions

Olanzapine 2 netupitant 1 ginger extract 1 Therapeutics 1 Palonosetron 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Instituto do Cancer do Estado de São Paulo

Phase 2/3 Completed

Nausea, Vomiting, Postoperative Nausea and Vomiting

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

University of Alabama at Birmingham

Phase 2/3 Completed

30 enrolled 9 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡